Media

Media contact

Media library

Fast facts

Page last modified 07 August 2020

Compliance Hotline Report Adverse Drug Reaction

You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.

Choose region and then country

Other Lundbeck sites

Global contacts

Media

Welcome to the media section

Latest releases

Lundbeck discontinues phase II proof of concept study of Lu AF11167 in patients with negative symptoms of schizophrenia

Lundbeck plans to refocus and reinvigorate Research & Development

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Strong momentum across all strategic brands with 35% growth in Q1 2020, financial guidance maintained

High school students compete online in developing future medicines

Media contact

General press enquiries, please call +45 3643 4000

Media library

Access visual aids for stories about Lundbeck

Fast facts

Get a quick overview of Lundbeck and our business